Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.

Here’s what science actually shows about declining testosterone in young adults, and why treatment is rarely the first answer ...

Hypogonadism was present in 42.8% of subjects, yet TRT was used by only 3.9%. NEW ORLEANS—Testosterone replacement therapy (TRT) is seldom prescribed to hypogonadal men, researchers reported at the ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Spoiler alert: You can stop TRT — but the way you do so matters. Stopping abruptly often restores previous symptoms of low ...

Testosterone replacement therapy (TRT) is not associated with aggressive prostate cancer (PCa) and does not increase overall or disease-specific mortality, according to a study that also revealed that ...

Although the Endocrine Society guidelines recommend TRT for men with testosterone levels ≤ 300 ng/dL in two morning samples, a primary concern is its potential to exacerbate prostate-related ...

Spoiler alert: You can stop TRT — but the way you do so matters. Stopping abruptly often restores previous symptoms of low testosterone, and recovering natural testosterone production levels isn’t a ...